Women gather to listen to President Donald Trump at a Women’s History Month event in the East Room of the White House in March 2025. The U.S. Food and Drug Administration this month acknowledged a nationwide shortage of estrogen-based hormonal patches, which are prescribed for women experiencing symptoms related to menopause. (Photo by Win McNamee/Getty Images) The U.S. Food and Drug Administration says it’s helping manufacturers increase the supply of estrogen-based hormonal patches and acknowledged a current nationwide shortage as more women seek hormonal therapies for symptoms related to menopause. In a release earlier this month, the FDA said it is expediting actions to increase supply, and said all six manufacturers are working to expand capacity and prioritize production of the patches. “The FDA views increased interest in menopause treatment as an important development for women’s health and is working closely with manufacturers to help ensure that the supply of estradiol patc...